Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/2/2026

Evidence‑Based Tapering Strategy for Mirtazapine

  • Reducing the daily dose by 25 % every 1–2 weeks (from 30 mg to 22.5 mg, then to 15 mg) provides a safe tapering plan for patients wishing to halve their dose【1】【2】.
  • Weeks 1‑2: Decrease to 22.5 mg nightly; this can be achieved with a combination of a 15 mg tablet plus a 7.5 mg tablet, or by alternating a 30 mg tablet with a 15 mg tablet every other night during the initial period【1】【2】.
  • Weeks 3‑4: Reduce to the target dose of 15 mg nightly【1】.

Rationale for Gradual Reduction

  • A stepwise 25 % reduction minimizes withdrawal symptoms while still achieving the intended dose decrease【1】.

Management of Intolerable Withdrawal Symptoms

  • When withdrawal symptoms become intolerable, slowing the taper further—using smaller dose increments over longer intervals—is recommended【1】.

Patient Collaboration and Shared Decision‑Making

  • Successful tapering requires patient agreement and collaborative planning, including joint decisions about taper pacing and the use of pauses if needed【3】【4】.

REFERENCES